India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
** Shares of India's GlaxoSmithKline Pharmaceuticals GLAX.NS jump as much as 2.26% to 2,466.20 rupees ** Pharma company's quarterly profit rose 5.7% to 2.78 billion rupees ($28.98 million); revenue was up ~2.1% ** Motilal Oswal lifts PT by 8% to 2,600 rupees on improving earnings visibility led by scale-up of innovative portfolio ** Expects 16% earnings CAGR over FY26–FY28; largely maintains estimates for FY27 and FY28 ** YTD, stock down ~2% ($1 = 95.9275 Indian rupees) (Reporting by Bipasha Dey in Bengaluru) ((Bipasha.Dey@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsIndia's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees
India's Cipla jumps on FDA approval for Ventolin HFA generic inhaler
Brief: Glaxosmithkline Pharmaceuticals Receives TDS Demand Liability Of 20.1 Million Rupees
Brief: Glaxosmithkline Pharmaceuticals Ltd Receives Final Order With Tax Demand Liability Of 232.1 Mln Rupees For AY 2023-24